Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Capital on the Frontier Measure Better Investing in Racial Equity Beyond Trade-offs Impact en las Americas New Revivalists
Local and Inclusive Climate Finance Catalytic Capital Frontier Finance Best Practices Geographies
Slack Agent of Impact Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Locavesting Entrepreneurship Gender Smart Return on Inclusion Good Jobs Creative economy Opportunity Zones Investing in place Housing New Schooled Well Being People on the Move Faith and investing Inclusive Fintech
Clean Energy Farmer Finance Soil Wealth Conservation Finance Financing Fish
Innovative Finance
Personal Finance Impact Management
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States
Subscribe Log In

Femtech funding tops $1 billion as women’s health takes center stage

Women Rising

Startups targeting women’s healthcare have raised $1.1 billion in venture financing since 2014, CB Insights reports.

Prelude, a fertility solutions startup, has raised $200 million and Progyny, backed by Kleiner Perkins, has raised $49 million for its egg-freezing and fertility services. Reproductive therapeutics company ObsEva, based in Geneva, filed for an IPO.

The global femtech market includes Dayima, a Beijing-based menstrual health app maker, which raised $70 million in 2015.

Photo: CB Insights

You might also like...